Federal grants to The Critical Path Institute
The Critical Path Institute in Tucson, Arizona received $94.0 million in federal grants from fiscal 2021 to 2025, across 13 awards. Its largest program was Food and Drug Administration Research, with $94.0 million. In fiscal 2025 it was awarded $24.4 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$94.0 million
- Awards13
- Awarded in FY 2025$24.4 million
- Largest award$87.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $14.9 million |
| FY 2022 | 3 | $21.4 million |
| FY 2023 | 2 | $16.6 million |
| FY 2024 | 6 | $16.6 million |
| FY 2025 | 4 | $24.4 million |
Programs that fund The Critical Path Institute
| Program | Awards | Amount |
|---|---|---|
| Food and Drug Administration Research | 13 | $94.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 13 | $94.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Critical path public private partnerships | Food and Drug Administration Research | December 21, 2020 | $87.7 million |
| Advancing standards and methodologies to generate real world evidence from real world data through a neonatal pilot project | Food and Drug Administration Research | July 9, 2021 | $3.3 million |
| Development of a qualification plan for the virtual reality functional capacity assessment tool - short list (vrfcat-slx) (ddt coa #000004) - abstract nearly 7 million people in the united states are living with alzheimer’s disease (AD). As people with ad progress through the stages of this disease, | Food and Drug Administration Research | September 2, 2024 | $499,946 |
| Psychometric analyses and quantitative study report for qualification of the chronic heart failure symptom scale (chf-ss) (ddt coa #000112) - abstract heart failure is a major worldwide health problem, with a prevalence of over 6.2 million in the united states (US), and over 26 million worldwide. He | Food and Drug Administration Research | September 2, 2024 | $498,104 |
| Psychometric analyses and quantitative study report for qualification of the pediatric asthma diary-child (pad-c) and the pediatric asthma diary-observer (pad-o) (ddt coa #000099) - abstract asthma is one of the most common childhood chronic conditions worldwide. In the united states (US), asthma pr | Food and Drug Administration Research | September 10, 2025 | $250,000 |
| Development of a full qualification package for the promis short form V1.0?fatigue-multiple sclerosis 8A (ddt coa #000069) - abstract over 1 million people in the united states are living with multiple sclerosis (MS), and the majority of people with ms are likely to experience severe, debilitating f | Food and Drug Administration Research | September 20, 2022 | $249,989 |
| Preparation and submission support of a full qualification package (FQP) for the diary for irritable bowel syndrome symptoms—diarrhea (dibss-d) (ddt #000148) - abstract irritable bowel syndrome (IBS) is a chronic, oftentimes disabling gastrointestinal disorder characterized by recurrent abdominal pa | Food and Drug Administration Research | April 5, 2024 | $249,979 |
| Development of a full qualification package (FQP) for the promisnq short form V2.0 - physical function - multiple sclerosis 15A (ddt coa #000123) - abstract over 1 million people in the united states are living with multiple sclerosis (MS), a disease that has significant impacts on physical function | Food and Drug Administration Research | February 1, 2024 | $249,975 |
| Development of a qualification plan for an activity monitor-based endpoint measure in chronic heart failure (ddt coa #000114) - abstract chronic heart failure (CHF) results when the heart cannot pump enough blood to meet the body’s needs. Approximately 6.5 million people in the united states and 26 | Food and Drug Administration Research | August 17, 2021 | $249,970 |
| Sample collection and analysis to support the qualification plan for drug induced skeletal muscle injury biomarker panel for DDT-BMQ-000081. - abstract this project seeks to increase our understanding of the sensitivity of the four proposed skeletal muscle injury biomarkers to detect drug-induced sk | Food and Drug Administration Research | August 17, 2021 | $247,231 |
Questions people ask
How much federal grant money does The Critical Path Institute get?
$94.0 million in 13 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Critical Path Institute the most?
The Department of Health and Human Services, with $94.0 million in 13 awards.
What is The Critical Path Institute's largest federal grant?
$87.7 million under Food and Drug Administration Research, with its first action in the period on December 21, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Tucson
- University of Arizona
- Association of Universities for Research in Astronomy, Inc.
- City of Tucson
- Tucson Airport Authority Inc
- Child-Parent Centers, Inc.
- Visionquest National LTD
- SOUTH32 Hermosa Inc
- Pascua Yaqui Tribe
Largest federal grant recipients in Arizona · Federal grants in Arizona